BlackRock Institutional Trust Company, N.A. - IMPAX LABORATORIES INC ownership

IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of IMPAX LABORATORIES INC
ValueSharesWeighting
Q4 2016$24,643,000
-40.9%
1,859,829
+5.7%
0.00%
-33.3%
Q3 2016$41,691,000
-16.4%
1,759,121
+1.7%
0.01%
-25.0%
Q2 2016$49,864,000
-9.6%
1,730,188
+0.5%
0.01%
-11.1%
Q1 2016$55,133,000
-23.3%
1,721,824
+2.4%
0.01%
-25.0%
Q4 2015$71,895,000
+23.8%
1,681,366
+2.0%
0.01%
+20.0%
Q3 2015$58,064,000
-24.8%
1,649,071
-1.9%
0.01%
-16.7%
Q2 2015$77,212,000
-8.8%
1,681,443
-7.0%
0.01%
-7.7%
Q1 2015$84,701,000
+48.1%
1,807,155
+0.1%
0.01%
+44.4%
Q4 2014$57,193,000
+31.3%
1,805,324
-1.7%
0.01%
+28.6%
Q3 2014$43,543,000
-23.3%
1,836,462
-2.9%
0.01%
-22.2%
Q2 2014$56,749,000
+10.1%
1,892,266
-3.0%
0.01%0.0%
Q1 2014$51,521,000
+8.4%
1,950,085
+3.2%
0.01%
+12.5%
Q4 2013$47,515,000
+2.1%
1,890,016
-16.9%
0.01%
-11.1%
Q3 2013$46,555,000
+24.9%
2,274,287
+21.7%
0.01%
+12.5%
Q2 2013$37,264,0001,868,9750.01%
Other shareholders
IMPAX LABORATORIES INC shareholders Q4 2013
NameSharesValueWeighting ↓
Orbimed Advisors 5,415,600$162,414,0001.91%
Broadfin Capital, LLC 1,217,858$36,524,0001.80%
NEW AMSTERDAM PARTNERS LLC/NY 695,100$20,846,0001.36%
Healthcare Value Capital, LLC 50,000$1,500,0001.26%
Iguana Healthcare Management, LLC 75,000$2,249,0001.05%
Matarin Capital Management, LLC 78,292$2,347,977,0001.04%
Independence Capital Asset Partners, LLC 253,089$7,590,0001.04%
Tekla Capital Management LLC 344,683$10,337,0000.95%
Penn Capital Management Company, LLC 794,641$23,831,0000.92%
Leonard Capital Management, Inc. 87,661$2,629,0000.89%
View complete list of IMPAX LABORATORIES INC shareholders